Subsequent univariate analysis found p-RPS6KB1, along with clinical factors of tumor histological differentiation and TNM stage, also greatly associated with the median survival time in NSCLC patients, and the multivariate Cox regression analysis confirmed its independently prognostic predicting value. This evidence concerns the gene RPS6KB1 and neoplasm.